Results 11 to 20 of about 12,470 (162)

The dilemma of thymectomy in myasthenia gravis

Apollo Medicine, 2020
Myasthenia gravis (MG) is an autoimmune disease that affects the neuromuscular junction causing fluctuating weakness of skeletal muscles. It is considered a rare disease with an estimated prevalence of 7.77/100,000.
Pushpendra Nath Renjen, Dinesh Mohan Chaudhari, Anjali Mishra   +2 more
doaj   +1 more source

Real‐world application of plasmapheresis for neurological disease: Results from the Japan‐Plasmapheresis Outcome and Practice Patterns Study

Therapeutic Apheresis and Dialysis, Volume 27, Issue 1, Page 123-135, February 2023., 2023
Abstract Introduction Plasmapheresis is a well‐recognized treatment for autoimmune neurological diseases in Japan. However, the practice varies depending on the facility, and the actual treatment conditions are unclear. Methods To clarify real‐world conditions, a prospective observational study was conducted on patients with neurological diseases who ...
Youwei Lin, Satoru Oji, Katsuichi Miyamoto, Tomoko Narita, Mana Kameyama, Hidenori Matsuo   +5 more
wiley   +1 more source

Surgical resection combined with perioperative chemotherapy for a patient with locally recurrent, previously stage IV thymic small‐cell carcinoma: A case report

Thoracic Cancer, Volume 13, Issue 23, Page 3415-3419, December 2022., 2022
We present the case of an elderly man with thymic small‐cell carcinoma, a thymic neuroendocrine tumor, where multidisciplinary treatment, including chemotherapy comprising carboplatin and etoposide, and salvage surgery, was considered effective. Chest computed tomography scans show that 4 months after initiation of chemotherapy, the tumor and pleural ...
Junki Terada, Yuko Toyoda, Eiji Takeuchi, Nobuyuki Tanida, Satoshi Ito, Kenji Yorita, Hisashi Matsuoka, Hiroki Bando, Yutaka Morita, Yuri Okamoto, Tsutomu Shinohara   +10 more
wiley   +1 more source

Prognostic factors and genetic markers in thymic epithelial tumors: A narrative review

Thoracic Cancer, Volume 13, Issue 23, Page 3242-3249, December 2022., 2022
The aim of this review article is to discuss the different prognostic factors and genetic markers of TET and to point out discrepancies and similarities among the available literature (concerning prognostic factors) and more importantly to demonstrate the genetic pathways that could be the basis of a development of new targeted therapies.
Apostolos C. Agrafiotis, Vasiliki Siozopoulou, Jeroen M. H. Hendriks, Patrick Pauwels, Senada Koljenovic, Paul E. Van Schil   +5 more
wiley   +1 more source

Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal

European Journal of Neurology, Volume 30, Issue 1, Page 266-282, January 2023., 2023
Myasthenia gravis is recognized as an immunoglobulin G autoantibody‐mediated disease, but the relationship between autoantibody levels and disease activity is unclear. We conducted a systematic literature review to evaluate this landscape, which yielded 10 studies mainly describing a positive, significant correlation.
Andreas Meisel, Fulvio Baggi, Anthony Behin, Amelia Evoli, Anna Kostera‐Pruszczyk, Renato Mantegazza, Raul Juntas Morales, Anna Rostedt Punga, Sabrina Sacconi, Michael Schroeter, Jan Verschuuren, Louise Crathorne, Kris Holmes, Maria‐Isabel Leite   +13 more
wiley   +1 more source

European multicentre study on outcome of surgery for sporadic primary hyperparathyroidism

BJS (British Journal of Surgery), EarlyView., 2020
Some 5861 patients undergoing first‐time surgery for sporadic primary hyperparathyroidism were registered in the Eurocrine® database between 2015 and 2018. The use of intraoperative parathyroid hormone measurement decreased the risk of conversion and persistent hypercalcaemia.
A. Bergenfelz, S. van Slycke, Ö. Makay, L. Brunaud   +3 more
wiley   +1 more source

Effects of thymectomy on late-onset non-thymomatous myasthenia gravis: systematic review and meta-analysis

Orphanet Journal of Rare Diseases, 2021
Background The effects of thymectomy on late-onset non-thymomatous myasthenia gravis (NTMG) remain controversial. The objective of this study was to conduct a systematic review in order to answer two questions pertinent to late-onset NTMG: (1) do ...
Jinwei Zhang, Yuan Chen, Hui Zhang, Zhaoyu Yang, Peng Zhang   +4 more
doaj   +1 more source

Thymoma‐associated myasthenia gravis: Clinical features and predictive value of antiacetylcholine receptor antibodies in the risk of recurrence of thymoma

Thoracic Cancer, 2021
Background Thymoma‐associated myasthenia gravis (TAMG) is one of the subtypes of myasthenia gravis with autoantibodies against the acetylcholine receptor (AChR‐Ab).
Anna De Rosa, Marco Fornili, Michelangelo Maestri Tassoni, Melania Guida, Laura Baglietto, Loredana Petrucci, Antonio Chella, Franca Melfi, Marco Lucchi, Roberta Ricciardi   +9 more
doaj   +1 more source

Effect Evaluation of Subxiphoid and Intercostal Thymectomy: A Meta-Analysis and Systematic Review

Frontiers in Surgery, 2022
BackgroundIt still remains unclear whether subxiphoid video-assisted thoracoscopic surgery (SVATS) thymectomy is safe and reasonable. This meta-analysis aims at assessing the effectiveness and safety of SVATS for thymoma in comparison with that of ...
Hailong Wang, Miao Wang, Ning Xin, Rongqiang Wei, Kenan Huang, Kenan Huang   +5 more
doaj   +1 more source

Thymectomy for myasthenia gravis: Video-assisted versus transsternal

Journal of the Formosan Medical Association, 2014
Thymectomy may benefit patients with generalized myasthenia gravis (MG) or myasthenia with thymomas. Currently, video-assisted (VA) thoracic surgery is popular and plays an important role in thymectomy.
Chien-Ming Lo, Hung-I. Lu, Ming-Jang Hsieh, Shao-Shuan Lee, Jen-Ping Chang   +4 more
doaj   +1 more source